Maternal antibodies to rotavirus and their potential interference with live, oral rotavirus vaccines in developing countries
Vaccine strategies to overcome early infant infection, including neonatal and maternal vaccination, will be discussed with a focus on the development of the RV3 neonatal Rotavirus Vaccine being developed by the MCRI